Viewing Study NCT03494569


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-03 @ 11:36 PM
Study NCT ID: NCT03494569
Status: RECRUITING
Last Update Posted: 2025-11-07
First Post: 2018-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 17505
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View